Literature DB >> 33530146

Cardiovascular co-morbidity in cancer patients: the role of psychological distress.

Dounya Schoormans1, Susanne S Pedersen2,3, Susanne Dalton4, Nina Rottmann2,5, Lonneke van de Poll-Franse6,7,8.   

Abstract

Due to aging of the population and cardiotoxic cancer treatment, there is an increasing group of patients with cancer and co-morbid cardiovascular disease (CVD). In order to find a balance between the risk of undertreating the malignancy on the one hand and inducing CVD on the other hand, CVD risk stratification at the time of cancer diagnosis and knowledge on the pathway for developing incident CVD in cancer patients is vital. In this paper, we propose an adapted multiple-hit hypothesis for developing CVD in cancer patients describing that patients with cancer are exposed to a series of sequential or concurrent events that together make them more vulnerable to reduced cardiovascular reserves, development of incident CVD and ultimately death. We highlight the possible impact of psychological distress secondary to a cancer diagnosis and/or treatment, which in turn may increase the risk of incident CVD in patients diagnosed with cancer. Furthermore, we discuss potential behavioral and pathophysiological mechanisms underlying the link between psychological distress and the pathophysiology of incident CVD. In addition, key unanswered questions for future research are posed. In the future, researching the adapted multiple-hit hypothesis for developing CVD among cancer patients will hopefully advance the care of cancer patients by finding some of the missing pieces of the puzzle. To do so, we need to focus on minimizing cardiovascular risk and promoting cardiovascular health in cancer patients by addressing the knowledge gaps formulated in this paper.

Entities:  

Keywords:  Cancer; Cardiovascular; Mechanisms; Psychological distress; Survivors

Year:  2016        PMID: 33530146     DOI: 10.1186/s40959-016-0019-x

Source DB:  PubMed          Journal:  Cardiooncology        ISSN: 2057-3804


  55 in total

1.  The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society.

Authors:  Daniel J Lenihan; Daniela Cardinale; Carlo M Cipolla
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

Review 2.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

Review 4.  Anticancer therapy induced cardiotoxicity: review of the literature.

Authors:  Sandra Geiger; Veronika Lange; Patricia Suhl; Volker Heinemann; Hans-Joachim Stemmler
Journal:  Anticancer Drugs       Date:  2010-07       Impact factor: 2.248

Review 5.  The management of cancer patients with heart disease.

Authors:  Kalina Kawecka-Jaszcz; Agnieszka Bednarek
Journal:  Przegl Lek       Date:  2012

6.  Long-term cause-specific mortality of patients treated for Hodgkin's disease.

Authors:  Berthe M P Aleman; Alexandra W van den Belt-Dusebout; Willem J Klokman; Mars B Van't Veer; Harry Bartelink; Flora E van Leeuwen
Journal:  J Clin Oncol       Date:  2003-07-28       Impact factor: 44.544

Review 7.  Early breast cancer therapy and cardiovascular injury.

Authors:  Lee W Jones; Mark J Haykowsky; Jonas J Swartz; Pamela S Douglas; John R Mackey
Journal:  J Am Coll Cardiol       Date:  2007-09-24       Impact factor: 24.094

Review 8.  Cardiotoxicity of cytotoxic drugs.

Authors:  Kirsten J M Schimmel; Dick J Richel; Renée B A van den Brink; Henk-Jan Guchelaar
Journal:  Cancer Treat Rev       Date:  2004-04       Impact factor: 12.111

9.  Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity.

Authors:  Maryska L G Janssen-Heijnen; Karolina Szerencsi; Saskia A M van de Schans; Huub A A M Maas; Jos W Widdershoven; Jan Willem W Coebergh
Journal:  Crit Rev Oncol Hematol       Date:  2009-12-29       Impact factor: 6.312

10.  Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).

Authors:  Michael Ewer; Luca Gianni; Fabrizio Pane; Maria Teresa Sandri; Rudolf K Steiner; Leszek Wojnowski; Edward T Yeh; Joseph R Carver; Steven E Lipshultz; Giorgio Minotti; Gregory T Armstrong; Daniela Cardinale; Steven D Colan; Sarah C Darby; Thomas L Force; Leontien Cm Kremer; Daniel J Lenihan; Stephen E Sallan; Douglas B Sawyer; Thomas M Suter; Sandra M Swain; Flora E van Leeuwen
Journal:  Ecancermedicalscience       Date:  2014-05-29
View more
  2 in total

1.  Cancer comorbidity in patients with non-obstructive coronary artery disease: Depressive symptoms related to C-reactive protein.

Authors:  Dounya Schoormans; Jos W Widdershoven; Paula M C Mommersteeg
Journal:  Brain Behav Immun Health       Date:  2020-05-30

2.  Risk of heart disease following treatment for breast cancer - results from a population-based cohort study.

Authors:  Haomin Yang; Nirmala Bhoo-Pathy; Judith S Brand; Elham Hedayati; Felix Grassmann; Erwei Zeng; Jonas Bergh; Weiwei Bian; Jonas F Ludvigsson; Per Hall; Kamila Czene
Journal:  Elife       Date:  2022-03-16       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.